Ontogenetic expression of spot 35 protein (calbindin-D28k) in human olfactory receptor neurons and its decrease in Alzheimer's disease patients

Annals of Otology, Rhinology and Laryngology

Volumn 105, Issue 2, 1996, Pages 132-139

  Yamagishi, Masuo ^a,b,c,d   Takami, Shigeru ^a,b,d   Getchell, Thomas V ^a,b,d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c Ina Central Hospital   (Japan)

^d NONE

Author keywords

Alzheimer's disease; calbindin D28k; human olfactory mucosa; immunohistochemistry; neuron specific enolase; olfactory marker protein; ontogeny; spot 35 protein

Indexed keywords

CALBINDIN; CALCIUM BINDING PROTEIN; CALCIUM ION; ENZYME ANTIBODY; NEURON SPECIFIC ENOLASE; PROTEIN ANTIBODY;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CALCIUM CELL LEVEL; CELL FUNCTION; CONTROLLED STUDY; FEMALE; FETUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; MALE; NERVE CELL EXCITABILITY; OLFACTORY EPITHELIUM; OLFACTORY NERVE; OLFACTORY RECEPTOR; ONTOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0030041067     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348949610500208     Document Type: Article

References (44)

1. Kennedy MB. Regulation of neuronal function by calcium. Trends Neurosci 1989;12:417-20.
2. Baimbridge KG, Celio MR, Rogers JH. Calcium-binding proteins in the nervous system. Trends Neurosci 1992;15:303-8.
3. Heizmann CW, Hunziker W. Intracellular calcium-binding proteins: more sites than insights. Trends Biochem Sci 1991;16:98-103.
4. Mattson MP, Rychlik B, Chu C, Christakos S. Evidence for calcium-reducing and excitoprotective roles for the calcium-binding protein calbindin-D28k in culturedhippocampal neurons. Neuron 1991;6:41-51.
5. 2+-binding protein parvalbumin. Neurosci Lett 1989;105:263-8.
6. Sloviter RS. Calcium-binding protein (calbindin-D28k) and parvalbumin immunoreactivity: localization in the rat hippocampus with specific reference to the selective vulnerability of hippocampal neurons to seizure activity. J Comp Neurol 1989:280: 182-96.
7. 2+-binding proteins in human neurodegenerative disorders. Trends Neurosci 1992;15:259-64.
8. Arai H, Emson PC, Mountjoy CQ, Carassco LH, Heizmann CW. Loss of parvalbumin-immunoreactive neurons from cortex in Alzheimer-type dementia. Brain Res 1987;418:164-9.
9. Ichimiya Y, Emson PC, Mountjoy CQ, Lawson DEM, Iizuka R. Calbindin-immunoreactive cholinergic neurons in the nucleus basalis of Meynert in Alzheimer-type dementia. Brain Res 1989;499:402-6.
10. Kobayashi K, Emson PC, Mountjoy CQ, Thornton SN, Lawson DEM, Mann DMA. Cerebral cortical calbindin D28K and parvalbumin neurons in Down's syndrome. Neurosci Lett 1990;113:17-22.
11. Abe H, Watanabe M, Kondo H. Developmental changes in expression of a calcium-binding protein (spot 35-calbindin) in the nervus terminalis and the vomeronasal and olfactory receptor cells. Acta Otolaryngol (Stockh) 1992;112:862-71.
12. Yoshida Y, Takahashi Y. Compositional changes in soluble proteins of cerebral mantle, cerebellum and brain stem of rat brain during development: a two-dimensional gel electrophoretic analysis. Neurochem Res 1980;5:81-96.
13. Yamakuni T, Usui H, Iwanaga T, Kondo H, Odani S, Takahashi Y. Isolation and immunohistochemical localization of a cerebellar protein. Neurosci Lett 1984;45:235-40.
14. Maruyama S, Zhang G, Tamura Y, Yamakuni T, Takahashi Y. Involvement of spot 35 protein, a cerebellar protein in modulation of Purkinje cell activity of the rat cerebellum. Eur J Pharmacol 1985;108:309-14.
15. Yamakuni T, Araki K, Takahashi Y. The developmental changes of mRNA levels for a cerebellar protein (spot 35 protein) in rat brains. FEBS Lett 1985;188:127-30.
16. Yamakuni T, Kuwano R, Odani S, Yamaguchi Y, Takahashi Y, Nucleotide sequence of cDNA to mRNA for a cerebellar Ca-binding protein, spot 35 protein. Nucleic Acids Res 1986; 14:6768.
17. Hunziker W, Schrickel S. Rat brain calbindin D28k: six domain structure and extensive amino acid homology with chicken calbindin D28. Mol Endocrinol 1988;2:465-73.
18. WoodTL, Kobayashi Y, Frantz G, Varghese S, Christakos S, Tobin AJ. Molecular cloning of mammalian 28,000 Mr vitamin D-dependent calcium binding protein (calbindin-D28k): expression of calbindin-D28k RNAs in rodent brain and kidney. DNA 1988;7:585-93.
19. Kishimoto J, Keverne EB, Emson PC. Calretinin, calbindin-D28k and parvalbumin-like immunoreactivity in mouse chemoreceptor neurons. Brain Res 1993;610:325-9.
20. Yamagishi M, Ishizuka Y, Fujiwara M, Nakamura H, Igarashi S, Kuwano R. Distribution of calcium binding proteins in sensory organs of the ear, nose and throat. Acta Otolaryngol Suppl (Stockh) 1993(suppl 506):85-9.
21. Yamagishi M, Nakamura H, Kuwano R. Immunohistochemical study of the fourth cell type of the olfactory epithelium in guinea pigs and in a patient. ORL 1992;54:85-90.
22. Firestein S, Zufall F. Membrane currents and mechanisms of olfactory transduction. In: ChadwickD, Marsh J, Goode J, eds. The molecular basis of smell and taste transduction. Chichester, England: John Wiley & Sons, 1993:115-30.
23. 2+ gradients in rat olfactory neurons. J Gen Physiol 1993;102:907-24.
24. Nakamura T, Gold GH. A cyclic nucleotide-gated conductance in olfactory receptor cilia. Nature 1987;325:442-4.
25. 2+-dependent adaptive properties in the solitary olfactory receptor cells of the newt. Brain Res 1990;515:261-8.
26. Zufall F, Firestein S. Divalent cations block the cyclic nucleotide-gated channel of olfactory receptor neurons. J Neurophysiol 1993;69:1758-68.
27. Maue RA, Dionne VE. Patch-clamp studies of isolated mouse olfactory receptor neurons. J Gen Physiol 1987;90:95-125.
28. 2+. Biophys J 1993;64:1961-6.
29. Getchell ML, GetchellTV. Differential expression of cell-specific molecules in olfactory receptor neurons of humans of different ages. In: Kurihara K, Suzuki N, Ogawa H, eds. Olfaction and taste XI. Berlin, Germany: Springer-Verlag, 1994:602-3.
30. Farbman AI, Margolis FL. Olfactory marker protein during ontogeny: immunohistochemical localization. Dev Biol 1980;74:205-15.
31. Monti Graziadei GA, Stanley RS, Graziadei PPC. The olfactory marker protein in the olfactory system of the mouse during development. Neuroscience 1980;5:1239-51.
32. Iacopino AM, Christakos S. Specific reduction of calcium-binding protein(28-kilodalton calbindin-D) gene expression in aging and neurodegenerative disease. Proc Natl Acad Sci USA 1990;87:4078-82.
33. Hof PR, Morrison JH. Neocortical neuronal antibody to calbindin exhibits differential vulnerability in Alzheimer's disease. Exp Neurol 1991;111:293-301.
34. Hoffman SR, Quigley JB Jr, Harrington KM, Kowall NW, McKee AC. Calbindin D28K immunoreactive neurons in temporal isocortex resist degeneration in Alzheimer's disease [Abstract]. J Neuropathol Exp Neurol 1989;48:331.
35. Kohr G, Lambert CE, Mody I. Calbindin-D28k (CaBP) levels and calcium currents in acutely dissociated epileptic neurons. Exp Brain Res 1991;85:543-51.
36. Waldton S. Clinical observations of impaired cranial nerve function in senile dementia. Acta Psychiatr Scand 1975; 50:539-47.
37. Rezek DL. Olfactory deficits as a neurologic sign in dementia of the Alzheimer type. Arch Neurol 1987;44:1030-2.
38. Feldman JI, Murphy C, Davidson TM, Jalowayski AA, Galindo de Jaime G. The rhinologic evaluation of Alzheimer's disease. Laryngoscope 1991;101:1198-202.
39. Doty RL. Olfactory dysfunction in neurodegenerative disorders. In: Getchell TV, Doty RL, Bartoshuk LM, Snow JB Jr, eds. Smell and taste in health and disease. New York, NY: Raven Press, 1991:735-51.
40. Laccourreye L, Brouillard M, Emile J, Barthelaix AP. Monquese olfactiva et maladied' Alzheimer. Technique biopsique et etude ultrastructurale. Ann Otolaryngol 1991;108:277-85.
41. Tabaton M, Cammarata S, Mancardi GL, Cordone G, Perry G, Lobe C. Abnormal tau-reactive filaments in olfactory mucosa in biopsy specimens of patients with probable Alzheimer's disease. Neurology 1991;41:391-4.
42. Yamagishi M, Ishizuka Y, Seki K. Pathology of olfactory mucosa in patients with Alzheimer's disease. Ann Otol Rhinol Laryngol 1994;103:421-7.
43. Talamo BR, Rudel RA, Kosik KS, et al. Pathological changes in olfactory neurons in patients with Alzheimer's disease. Nature 1989;337:736-9.
44. Lee JH, Goedert M, Hill WD, Lee VM-Y, Trojanowski JQ. Tau proteins are abnormally expressed in olfactory epithelium of Alzheimer patients and developmentally regulated in human fetal spinal cord. Exp Neurol 1993;121:93-105.